Increasing Prevalence Of Genetic Disorders Fuels Growth In Genetic Testing Services Market: Strategic Insights Driving DNA Testing Market Momentum in 2025

"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the DNA Testing Market Size By 2025?
In recent years, the DNA testing market has seen accelerated expansion. The market is predicted to inflate from $17.9 billion in 2024 to about $20.08 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.2%. Historic growth can be tied to factors such as heightened incidence of chronic diseases, an escalating demand for precision medicine as well as direct-to-consumer (DTC) testing, increasing need for population genomics, a surge in forensic investigations, and a burgeoning demand for genetic screening.

How Big Is the DNA Testing Market Size Expected to Grow by 2029?
A fast-paced surge is expected in the DNA testing market size in the upcoming years. It is anticipated to reach a value of $31.38 billion in 2029, with a compound annual growth rate (CAGR) of 11.8%. Factors contributing to the growth in the projection period include an increase in genetic disease cases, the expanding use of DNA diagnostic tools, enhanced healthcare infrastructure, heightened awareness of disease prevention, increased manufacturing investment, and greater acceptance of companion diagnostics. Noteworthy trends in the projection period involve next-generation sequencing (NGS), polymerase chain reaction (PCR), preimplantation genetic diagnosis (PGD) in assisted reproductive technologies (art), downsizing of testing devices, introduction of new DNA testing products, and the emerging development of novel assays, biomarkers, diagnostic tools, point-of-care testing, and non-invasive prenatal testing (NIPT).

View the full report here:
https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

Which Key Market Drivers Powering DNA Testing Market Expansion and Growth?
The DNA testing market is anticipated to grow due to the rising incidence of genetic disorders globally. These disorders, caused by DNA abnormalities in individuals, result in physical or developmental irregularities. This escalating incidence is linked to factors such as growing awareness, enhanced diagnostic methods, wider genetic screening, and the prevalent practice of consanguineous marriages in certain communities. DNA testing plays a pivotal role in the diagnosis, prognosis, and therapeutic decision-making for people with genetic disorders, allowing for personalized healthcare and familial planning based on an individual's genetic sequence. For example, the World Health Organization, a Switzerland-based specialized division of the United Nations responsible for international public health reported in February 2023 that congenital diseases were responsible for an estimated 240,000 infant deaths worldwide within the first 28 days every year. Furthermore, the US government-run Centers for Disease Control and Prevention reported that approximately 6,000 babies with Down syndrome are born annually in the US, translating to 1 out of 700 babies. Thus, the surge in genetic disorders prevalence is fueling the advancement of the DNA testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15358&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the DNA Testing Market?
Top-tier companies in the DNA testing market are concentrating their efforts on creating sophisticated testing solutions such as DNA tests for the early detection of precancer. Early detection DNA tests aim to identify genetic changes or biomarkers related to the initial phases of cancer growth. For example, in November 2023, Lucid Diagnostics Inc., an American medical diagnostics firm specializing in preventing esophageal cancer, unveiled an updated version of their EsoGuard Esophageal DNA Test, known as EsoGuard 2.0. This cutting-edge esophageal DNA test deploys molecular methods and better yields from DNA samples to improve the assay's effectiveness and minimize expenses. The testing process involves gathering DNA from cells in the esophagus using the EsoCheck Cell Collection Device, followed by bisulfite conversion, polymerase chain reaction (PCR) amplification, and next-generation sequencing to detect methylation on specific gene sites linked to esophageal precancer and cancer. This DNA test returns results that point to the existence or non-existence of epigenetic changes linked with esophageal precancer and cancer, making it a vital tool for cancer prevention and early detection.

What Are the Emerging Segments in the DNA Testing Market?
The DNA testing market covered in this report is segmented -

1) By Product Type: Equipment, Consumables, Software And Services
2) By Technology: Polymerase Chain Reaction (PCR) Based, In-Situ Hybridization, Microarray, Next-Generation Sequencing (NGS) DNA Diagnosis
3) By Application: Newborn DNA Screening, Pre-Natal DNA Carrier Screening, Oncology Diagnostics And Histopathology, Pre-implantation Diagnosis, Infectious Disease Diagnostics, Pharmacogenomics Diagnostic Testing, Identify Diagnostics And Forensic, Other Applications

Subsegments:
1) By Equipment: DNA Analyzers, PCR (Polymerase Chain Reaction) Machines, Sequencers, Electrophoresis Systems, Other DNA Testing Instruments
2) By Consumables: Reagents And Kits, PCR Consumables (Primers, Probes), DNA Extraction Kits, Sample Collection Devices, Others (DNA Markers, Electrophoresis Gels)
3) By Software: Data Analysis Software, Laboratory Information Management System (LIMS), Genetic Analysis Software, Bioinformatics Software, Other DNA Testing Software Solutions
4) By Services: Testing Services (Genetic Testing, Forensic Testing, Etc.), Data Interpretation Services, Consultation Services (Genetic Counseling), Laboratory Services (Sample Processing, DNA Sequencing Services), Other DNA Testing Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15358&type=smp

Who Are the Global Leaders in the DNA Testing Market?
Major companies operating in the DNA testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., Ancestry.com LLC, 23andMe Holding Co, Ambry Genetics Corporation, MyHeritage Ltd., Biocartis SA, CENTOGENE N.V., Everlywell Inc., Atlas Biomed Group Limited, Veritas Genetics

Which are the Top Profitable Regional Markets for the DNA Testing Industry?
North America was the largest region in the DNA testing market in 2024. The regions covered in the DNA testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15358

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.